sodium phenylacetate and sodium benzoate

FDA Drug Profile — SODIUM PHENYLACETATE AND SODIUM BENZOATE, SODIUM PHENYLACETATE and SODIUM BENZOATE

Drug Details

Generic Name
sodium phenylacetate and sodium benzoate
Brand Names
SODIUM PHENYLACETATE AND SODIUM BENZOATE, SODIUM PHENYLACETATE and SODIUM BENZOATE
Application Number
ANDA205880
Sponsor
Zydus Pharmaceuticals USA Inc.
NDC Codes
5
Dosage Forms
INJECTION, SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients
SODIUM BENZOATE, SODIUM PHENYLACETATE

Indications and Usage

1 INDICATIONS AND USAGE Sodium Phenylacetate and Sodium Benzoate Injection is a nitrogen binding agent indicated as adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in paediatric and adult patients with deficiencies in enzymes of the urea cycle. ( 1 ) Sodium Phenylacetate and Sodium Benzoate Injection is indicated as adjunctive therapy in pediatric and adult patients for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. During acute hyperammonemic episodes, arginine supplementation, caloric supplementation, dietary protein restriction, hemodialysis, and other ammonia lowering therapies should be considered [ see Warnings and Precautions (5) ].